Home Publications

16

Sep2024

*NEW* Report Release: “Issues and Opportunities to Modernize Private Drug Plan Sustainability in an Evolving Market”

PDCI Market Access, a Division of McKesson Canada Corporation has released a whitepaper investigating the design and sustainability of private drug benefits in Canada. The report, commissioned by Innovative Medicines Canada, uncovers critical gaps in private insurance risk pooling that leave many small plan sponsors with tough decisions ... Read More

20

Jun2022

PRESS RELEASE: PDCI’s Biopharmaceutical Ecosystem Index: Where does Canada Rank on its Attractiveness for New Medicine Launch

Ottawa, June 20, 2022: PDCI study finds Canada Ranks 10th on its Attractiveness for New Medicine Launch Launched today by PDCI Market Access, a new study finds Canada ranks 10th out of 14 countries ... Read More

17

Dec2021

PDCI’s 2021 Census of Insurers

PDCI is pleased to announce the release of the 2021 update to the Census of Insurers. The Census of Insurers is available exclusively through the PDCI Market Access Toolkit. PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across Canada. Private payer and access managers ... Read More

17

Dec2021

New PDCI Market Access INSIGHTS Volume 2, Issue 1

PDCI releases new issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada. VOLUME 2, ISSUE 1... Read More

07

Dec2021

WHITEPAPER: Uncovering the Hidden Costs of Take-Home Cancer Drugs

In cancer care, patients often face increased anxiety and uncertainty about their future care pathway. This is paired with an immediate need for therapy to treat potentially aggressive disease. Coverage eligibility for THCD varies significantly across Canadian provinces, creating interprovincial differences. Gaps in coverage of THCDs across provinces lead to inequitable ... Read More

20

May2021

PDCI at ISPOR: Poster Presentation on Oncology Companion Diagnostics

ISPOR 2021 runs between May 17-20 with the theme of HEOR: Evolving for Tomorrow's Challenges. During the conference, PDCI Market Access will be presenting a poster titled: Identification of Gaps and Opportunities for Provincial Reimbursement of Oncology Companion Diagnostics in Canada on May 18th 2021 from 11:30:00 AM ... Read More

30

Sep2020

PDCI PLA Study Report – PDCI Market Access Inc., Connex Health Consulting, H3 Consulting

PDCI-PLA-Study-Report-PDCI-Market-Access-Inc.-Connex-Health-Consulting-H3-ConsultingDownload

09

Sep2020

Cell & Gene Therapy Insights

Palmer-Cell-and-Gene-Theraoy-InsightsDownload

14

Apr2020

Impact of COVID-19-Related Layoffs on Patients’ Access to Group Insurance

Bryan Ferguson, Editor, Insights Within 1-2 weeks, 1 million people laid off in March will begin to lose their health benefits.Laid-off patients who previously had access to drug insurance will now find themselves with no coverage or, if coverage continues, with reduced financial means to afford copayments and ... Read More

26

Feb2020

Introducing Between the Lines: A Canadian Pharmaceutical Industry Podcast

PDCI is pleased to inform you of the launch of its podcast series, Between the Lines. Between the Lines invites thought leaders and industry experts to share their insights about the trends and controversies that are shaping the pharmaceutical policy ... Read More